drugset / Trial / NCT03999580

The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )

NCT03999580

Phase 3 Unknown 316 enrolled Jantchou Prevost
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if vitamin D as an adjuvant therapy can improve the outcome (i.e. fewer relapses) and the quality of life, including levels of physical activity, in children diagnosed Crohn's disease (CD).

Timeline

Start
2020-02-07
Primary completion
2023-12
Completion
2024-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 600 iu Oral
Subject Cholecalciferol Other / unclassified 2000 iu Oral

Indications